UBS Group
CMRX

UBS Group’s Chimerix, Inc. CMRX Stock Holding History

UBS Group’s Portfolio CMRX Stock Details CMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-100
Closed -$4K – 8907
2015
Q1 		$4K Hold
100
– – ﹤0.01% 8250
2014
Q4 		$4K Buy
+100
New +$3.39K ﹤0.01% 9138

Other funds holding CMRX

Koshinski Asset Management
Koshinski Asset Management Decatur, Illinois $1.6B AUM 20.7% 1-Year Est. Return

UBS Group's CMRX Position: Q2 2025 in Review

UBS Group sold out of Chimerix, Inc. (CMRX) in Q2 2025, closing a stake of 2,901,056 shares — an estimated $24.7M sold.

UBS Group first reported a position in CMRX in Q4 2014 and held it in 42 quarters. The position peaked at $24.7M in Q1 2025. 1 fund tracked by Wall St. Rank holds CMRX as of Q2 2025.

  • UBS Group reported no remaining Chimerix, Inc. position as of Q2 2025 after selling out during the quarter.
  • UBS Group sold 2,901,056 Chimerix, Inc. shares in Q2 2025, an estimated $24.7M.
  • UBS Group first reported a position in Chimerix, Inc. in Q4 2014 and held it in 42 quarters.
  • UBS Group's Chimerix, Inc. position peaked at $24.7M in Q1 2025.
  • 1 fund tracked by Wall St. Rank held Chimerix, Inc. as of Q2 2025.

Based on UBS Group's 13F filing for Q2 2025, filed 14 Aug 2025.